Literature DB >> 26547122

Complication and Readmission Rates following Same-Day Discharge after Percutaneous Renal Tumor Ablation.

James X Chen1, Thomas J Guzzo2, S Bruce Malkowicz2, Michael C Soulen1, Alan J Wein2, Timothy W I Clark1, Gregory J Nadolski1, S William Stavropoulos3.   

Abstract

PURPOSE: To evaluate readmission rate and complications in patients undergoing same-day discharge following percutaneous thermal ablation of renal tumors.
MATERIALS AND METHODS: Patients undergoing same-day discharge following thermal ablation of renal tumors were reviewed. The primary outcome was the rate of readmission within 30 days of same-day discharge. The secondary outcomes included the rate and clinical outcomes of periprocedural complications.
RESULTS: Same-day discharge occurred in 166/174 patients (95%), of whom 2/166 (1%) required short-term readmission due to pulmonary embolism and acute-on-chronic kidney injury. Both patients recovered without permanent morbidity. Admission due to complications occurred in 8/174 (5%) cases, the majority of which were related to hemorrhage. No significant differences in rates of complications or admission were found between cryoablation and RF ablation. Major complications (Clavien-Dindo grade II or higher, SIR grade C or higher) occurred in 7/174 (4%) cases, the majority related to hemorrhage. All cases were detected in the standard 4 hour postprocedural observation period and managed conservatively. The mean hemorrhage volume was significantly larger in patients requiring admission versus those discharged the same day (289 mL vs 34 mL; P = .02). Higher-volume hemorrhage occurred in larger tumors (mean, 4.0 cm vs 3.0 cm; P = .04). There was no association between major complications and central tumor or age.
CONCLUSIONS: Routine same-day discharge following percutaneous renal tumor thermal ablation can be performed with a low rate of short-term readmission. The majority of periprocedural complications can be managed conservatively, and patients can be discharged the same day.
Copyright © 2016 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26547122     DOI: 10.1016/j.jvir.2015.09.007

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  7 in total

Review 1.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

2.  Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from Japanese experts.

Authors:  Masaya Miyazaki; Toshihiro Iguchi; Haruyuki Takaki; Takashi Yamanaka; Yoshitaka Tamura; Hiroyuki Tokue; Yozo Sato; Osamu Ikeda; Tadashi Shimizu; Koichiro Yamakado
Journal:  Jpn J Radiol       Date:  2016-07-23       Impact factor: 2.374

3.  Future scenarios and opportunities for interventional radiology in the post COVID-19 era.

Authors:  Jose Maria Abadal; Jimena Gonzalez-Nieto; Fernando Lopez-Zarraga; Miguel Angel de Gregorio; Panagiotis M Kitrou; Santiago Mendez
Journal:  Diagn Interv Radiol       Date:  2021-03       Impact factor: 2.630

4.  Management of Urinoma Formation After Laparoscopic Cryoablation of Renal Cyst.

Authors:  Shawn X Li; Lawrence M Dagrosa; Vernon M Pais
Journal:  J Endourol Case Rep       Date:  2017-01-01

5.  Percutaneous cryoablation for stage T1b renal cell carcinoma in a patient with horseshoe kidney.

Authors:  Kanichiro Shimizu; Hisayo Furube; Kenkichi Michimoto; Takafumi Yanagisawa; Jun Miki; Koichi Kishimoto; Shunichi Sadaoka
Journal:  Radiol Case Rep       Date:  2018-03-27

6.  Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes.

Authors:  Hongjin Shi; Jinze Li; Zhinan Fan; Jing Yang; Shi Fu; Haifeng Wang; Jiansong Wang; Jinsong Zhang
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

7.  Efficacy of antegrade and retrograde warm saline pyeloperfusion during renal cryoablation for ureteral preservation.

Authors:  Benjamin West; Mohamed Keheila; Jason C Smith; Alexander Erskine; Samuel R Abourbih; Nazih Khater; D Duane Baldwin
Journal:  Turk J Urol       Date:  2018-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.